BNKL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BNKL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.
Bionik Laboratories's quarterly accumulated depreciation increased from Sep. 2022 ($-0.62 Mil) to Dec. 2022 ($-0.64 Mil) and increased from Dec. 2022 ($-0.64 Mil) to Mar. 2023 ($-0.66 Mil).
Bionik Laboratories's annual accumulated depreciation increased from Mar. 2021 ($-0.59 Mil) to Mar. 2022 ($-0.60 Mil) and increased from Mar. 2022 ($-0.60 Mil) to Mar. 2023 ($-0.66 Mil).
The historical data trend for Bionik Laboratories's Accumulated Depreciation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionik Laboratories Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | |||||||||||
Accumulated Depreciation | Get a 7-Day Free Trial | -0.53 | -0.49 | -0.59 | -0.60 | -0.66 |
Bionik Laboratories Quarterly Data | ||||||||||||||||||||
Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | |
Accumulated Depreciation | Get a 7-Day Free Trial | -0.60 | -0.61 | -0.62 | -0.64 | -0.66 |
The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.
Thank you for viewing the detailed overview of Bionik Laboratories's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.
Remi Gaston-dreyfus | director, 10 percent owner | 46 RUE PIERRE CHARRON, PARIS I0 75008 |
Charles Matine | director | 7 RUE GUSTAVE, FLAUBERT, PARIS I0 75017 |
Andre-jacques Auberton-herve | director, officer: Chairman | 18 CHEMIN DE LA VIERGE NOIRE, LA TRONCHE I0 38700 |
Daniel Gonsalves | officer: Executive Vice President & CFO | 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472 |
Loren W. Wass | officer: See Remarks | 34 HOG HILL ROAD, PEPPERELL MA 01463 |
Joseph R Martin | director | |
Audrey Thevenon | director | 4500 WESTBROOK LANE, KENSINGTON MD 20895 |
Peter Gerald Malone | director | |
Russo Richard Paul Jr | officer: Chief Financial Officer | 20 PLUNKETT WAY, TEWKSBURY MA 01876 |
Renaud Bertrand Maloberti | officer: Chief Commercial Officer | 10 ACORN WAY, GEORGETOWN MA 01833 |
Timothy A. Mccarthy | officer: Chief Commercialization Office | C/O BIONIK, 483 BAY STREET, N105, TORONTO A6 M5G 2C9 |
Eric Michel Dusseux | director | 1 RUE DU CAPOT, CALUIRE-ET-CUIRE I0 69300 |
Jules Marc Fried | officer: VP - U.S. Operations | C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472 |
Hermano Igo Krebs | officer: Chief Science Officer | C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472 |
Marc Mathieu | director | 716 BROOKS AVENUE, VENICE CA 90291 |
From GuruFocus
By PRNewswire PRNewswire • 08-15-2018
By PRNewswire PRNewswire • 10-30-2018
By PRNewswire PRNewswire • 10-29-2018
By PRNewswire PRNewswire • 03-20-2018
By ACCESSWIRE ACCESSWIRE • 09-01-2022
By PRNewswire PRNewswire • 04-04-2018
By PRNewswire PRNewswire • 06-27-2018
By PRNewswire PRNewswire • 05-16-2018
By PRNewswire PRNewswire • 09-13-2018
By PRNewswire PRNewswire • 11-13-2018
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.